OTCMKTS:OCPNY - OLYMPUS CORP/S Stock Price, News, & Analysis

Get Started

$10.80 -0.05 (-0.46 %)

(As of 04/24/2019 12:14 PM ET)

Previous Close$10.85

Today's Range$10.80 - $10.80

52-Week Range$6.2625 - $11.65

Volume841 shs

Average Volume22,957 shs

Market Capitalization$14.80 billion

P/E Ratio28.42

Dividend YieldN/A

Beta0.82

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices. The company also provides upright, polarizing, inverted, laser scanning confocal, stereo, and marco fluorescence microscopes; box-type fluorescence imaging devices, microscope digital cameras, life science imaging software, bio-imaging systems, and virtual slide systems; metallurgical, semiconductor and flat-panel display inspection, laser scanning, and measuring microscopes; microscopic 3D measurement instruments, and industrial microscope ancillary equipment; and industrial videoscopes and fiberscopes, industrial rigidscopes and ancillary equipment, ultrasonic flaw detectors, eddy current and phased array flaw detectors, and X-ray fluorescence and X-ray diffraction analyzers. In addition, it offers interchangeable lens cameras, compact digital cameras, digital camera accessories, lens barrels units, optical components, digital audio recorders, binoculars, and related software applications; and biomedical materials system. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Receive OCPNY News and Ratings via Email

Sign-up to receive the latest news and ratings for OCPNY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Structural clay products

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:OCPNY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.olympus-global.com

Phone813-3340-2427

Debt

Debt-to-Equity Ratio0.28

Current Ratio1.58

Quick Ratio1.05

Price-To-Earnings

Trailing P/E Ratio28.42

Forward P/E Ratio270.00

P/E Growth3.55

Sales & Book Value

Annual Sales$7.10 billion

Price / Sales2.08

Cash Flow$0.7531 per share

Price / Cash Flow14.34

Book Value$2.92 per share

Price / Book3.70

Profitability

EPS (Most Recent Fiscal Year)$0.38

Net Income$513.57 million

Net Margins1.91%

Return on Equity3.50%

Return on Assets1.58%

Miscellaneous

Employees35,933

Outstanding Shares1,370,765,000

Market Cap$14.80 billion

Next Earnings Date5/10/2019 (Estimated)

OptionableNot Optionable

OLYMPUS CORP/S (OTCMKTS:OCPNY) Frequently Asked Questions

What is OLYMPUS CORP/S's stock symbol?

OLYMPUS CORP/S trades on the OTCMKTS under the ticker symbol "OCPNY."

How were OLYMPUS CORP/S's earnings last quarter?

OLYMPUS CORP/S (OTCMKTS:OCPNY) announced its earnings results on Friday, February, 8th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.37 by $0.06. The company had revenue of $1.77 billion for the quarter, compared to analyst estimates of $1.87 billion. OLYMPUS CORP/S had a return on equity of 3.50% and a net margin of 1.91%. View OLYMPUS CORP/S's Earnings History.

When is OLYMPUS CORP/S's next earnings date?

OLYMPUS CORP/S is scheduled to release their next quarterly earnings announcement on Friday, May 10th 2019. View Earnings Estimates for OLYMPUS CORP/S.

What is the consensus analysts' recommendation for OLYMPUS CORP/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OLYMPUS CORP/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for OLYMPUS CORP/S.

Has OLYMPUS CORP/S been receiving favorable news coverage?

News headlines about OCPNY stock have trended somewhat negative on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. OLYMPUS CORP/S earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave headlines about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the company's share price in the near future.

Who are some of OLYMPUS CORP/S's key competitors?

Some companies that are related to OLYMPUS CORP/S include Intuitive Surgical (ISRG), Shire (SHPG), Express Scripts (ESRX), Boston Scientific (BSX), Zoetis (ZTS), Illumina (ILMN), Allergan (AGN), Biogen (BIIB), Vertex Pharmaceuticals (VRTX), Shire (SHP), Merck KGaA (MRK), HCA Healthcare (HCA), Baxter International (BAX), Regeneron Pharmaceuticals (REGN) and Siemens Healthineers (SHL).

What other stocks do shareholders of OLYMPUS CORP/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OLYMPUS CORP/S investors own include Boston Scientific (BSX), ResMed (RMD), Applied Materials (AMAT), ASML (ASML), Clementia Pharmaceuticals (CMTA), eBay (EBAY), Fortinet (FTNT), Gilead Sciences (GILD), Sonic (SONC) and Foot Locker (FL).

Who are OLYMPUS CORP/S's key executives?

OLYMPUS CORP/S's management team includes the folowing people:

Mr. Yasuo Takeuchi, Pres, CEO & Director (Age 62)
Mr. Yasushi Sakai, CFO & Corp. Managing Officer
Mr. Akihiro Taguchi, COO, Sr. Corp. Managing Exec. Officer & Director (Age 61)
Mr. Haruo Ogawa, CTO, Sr. Exec. Managing Officer & Director (Age 62)
Mr. Stefan Kaufmann, Chief Admin. Officer, Corp. Officer (Age 51)

How do I buy shares of OLYMPUS CORP/S?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OLYMPUS CORP/S's stock price today?

One share of OCPNY stock can currently be purchased for approximately $10.80.

How big of a company is OLYMPUS CORP/S?

OLYMPUS CORP/S has a market capitalization of $14.80 billion and generates $7.10 billion in revenue each year. The company earns $513.57 million in net income (profit) each year or $0.38 on an earnings per share basis. OLYMPUS CORP/S employs 35,933 workers across the globe.

What is OLYMPUS CORP/S's official website?

The official website for OLYMPUS CORP/S is http://www.olympus-global.com.

How can I contact OLYMPUS CORP/S?

OLYMPUS CORP/S's mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2427 or via email at [email protected]

MarketBeat Community Rating for OLYMPUS CORP/S (OTCMKTS OCPNY)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		134 (Vote Outperform)
Underperform Votes:		158 (Vote Underperform)
Total Votes:		292

MarketBeat's community ratings are surveys of what our community members think about OLYMPUS CORP/S and other stocks. Vote "Outperform" if you believe OCPNY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCPNY will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 4/24/2019 by MarketBeat.com Staff

Featured Article: Initial Public Offering (IPO)